A brief quality-of-life measure for ALS clinical trials based on a subset of items from the sickness impact profile. The Syntex-Synergen ALS/CNTF Study Group - McGuire,D.; Garrison,L.; Armon,C. (J Neurol Sci (suppl 1), 1997)